Expanding the phenotypic spectrum of TUBB4A-associated hypomyelinating leukoencephalopathies.

Abstract

OBJECTIVE:

We performed whole-exome sequencing analysis of patients with genetically unsolved hypomyelinating leukoencephalopathies, identifying 8 patients with TUBB4A mutations and allowing the phenotypic spectrum of TUBB4A mutations to be investigated.

METHODS:

Fourteen patients with hypomyelinating leukoencephalopathies, 7 clinically diagnosed with hypomyelination with atrophy of the basal ganglia and cerebellum (H-ABC), and 7 with unclassified hypomyelinating leukoencephalopathy, were analyzed by whole-exome sequencing. The effect of the mutations on microtubule assembly was examined by mapping altered amino acids onto 3-dimensional models of the αβ-tubulin heterodimer.

RESULTS:

Six heterozygous missense mutations in TUBB4A, 5 of which are novel, were identified in 8 patients (6/7 patients with H-ABC [the remaining patient is an atypical case] and 2/7 patients with unclassified hypomyelinating leukoencephalopathy). In 4 cases with parental samples available, the mutations occurred de novo. Analysis of 3-dimensional models revealed that the p.Glu410Lys mutation, identified in patients with unclassified hypomyelinating leukoencephalopathy, directly impairs motor protein and/or microtubule-associated protein interactions with microtubules, whereas the other mutations affect longitudinal interactions for maintaining αβ-tubulin structure, suggesting different mechanisms in tubulin function impairment. In patients with the p.Glu410Lys mutation, basal ganglia atrophy was unobserved or minimal although extrapyramidal features were detected, suggesting its functional impairment.

CONCLUSIONS:

TUBB4A mutations cause typical H-ABC. Furthermore, TUBB4A mutations associate cases of unclassified hypomyelinating leukoencephalopathies with morphologically retained but functionally impaired basal ganglia, suggesting that TUBB4A-related hypomyelinating leukoencephalopathies encompass a broader clinical spectrum than previously expected. Extrapyramidal findings may be a key for consideration of TUBB4A mutations in hypomyelinating leukoencephalopathies.

• Authors: Satoko Miyatake, Hitoshi Osaka, Masaaki Shiina, Masayuki Sasaki, Jun-Ichi Takanashi, Kazuhiro Haginoya, Takahito Wada, Masafumi Morimoto, Naoki Ando, Yoji Ikuta, Mitsuko Nakashima, Yoshinori Tsurusaki, Noriko Miyake, Kazuhiro Ogata, Naomichi Matsumoto, Hirotomo Saitsu
• Journal: Neurology (Neurology) Vol. 82 Issue 24 Pg. 2230-7 (Jun 17 2014) ISSN: 1526-632X [Electronic] United States
• PMID: 24850488 (Publication Type: Journal Article, Research Support, Non-U.S. Gov't)
• Copyright: © 2014 American Academy of Neurology.

Chemical References

• TUBB4A protein, human
• Tubulin

Topics

• Adolescent
• Adult
• Basal Ganglia (pathology)
• Cerebellum (pathology)
• Child
• Child, Preschool
• DNA Mutational Analysis
• Demyelinating Diseases (complications, genetics)
• Exome (genetics)
• Female
• Genetic Predisposition to Disease
• Humans
• Infant
• Leukoencephalopathies (complications, genetics)
• Male
• Models, Molecular
• Mutation (genetics)
• Phenotype
• Tubulin (genetics)
• Young Adult